TMO Thermo Fisher Scientific Inc. - 8-K

Item 5.07    Submission of Matters to a Vote of Security Holders

At the Annual Meeting held on May  20, 2026, the shareholders of the Company voted on the following proposals:

1.    The following nominees were elected to the Company’s Board of Directors for a one-year term expiring at the 2027 annual meeting of shareholders.

For

Against

Abstain

Marc N. Casper

294,015,478

20,501,640

1,202,257

Nelson J. Chai

293,142,241

21,615,744

961,390

Ruby R. Chandy

312,259,374

2,490,403

969,598

C. Martin Harris

285,543,740

28,753,064

1,422,571

Tyler Jacks

304,372,357

10,373,697

973,321

Jennifer M. Johnson

304,583,443

10,151,215

984,717

R. Alexandra Keith

308,290,311

6,269,824

1,159,240

Karen S. Lynch

308,933,071

5,811,374

974,930

Debora L. Spar

314,426,121

311,821

981,433

Scott M. Sperling

292,218,754

22,524,675

975,946

Dion J. Weisler

281,791,656

32,960,105

967,614

2.    A non-binding, advisory proposal on the compensation of the Company’s named executive officers was not approved.

For

Against

Abstain

99,928,178

214,525,673

1,265,524

3.    The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified.

For

Against

Abstain

296,866,709

36,064,900

999,237